/Companies

St Teresa Medical

Woodbury, US · Founded 2010 · Minnesota corporation

Find your way into St Teresa Medical

Sign up to see every warm intro you have to St Teresa Medical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the St Teresa Medical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

St Teresa Medical develops nanotechnology-based hemostatic and wound-healing solutions for surgical applications, derived from battlefield trauma treatment technology. The company targets the hemostatic and therapeutic markets with fibers designed to control bleeding and support wound healing during surgery.

Founders & leadership

PA
PHILIP A. MESSINAExecutive
BJ
BRIAN JACKSONExecutive
CT
Charles Timothy Floyd MDExecutive
PA
PHILLIP A. MESSINAExecutive
DF
Dan FisherExecutive
ATAndrew T. Rock
Andrew T. RockChief Executive Officer & Chairman of the BoardAndrew T. Rock is CEO and Chairman of St Teresa Medical, which develops nanotechnology-based hemostatic and wound-healing solutions for surgical applications. He has held roles in sales and leadership across the medical technology sector, co-founded K2M Group (acquired by Stryker), and holds over 18 patents related to spine treatment.
TF
Timothy FloydChief Medical Officer
MPMichael Parkman
Michael ParkmanVice President of Sales

Board

LG
LAWRENCE G. SUCSYBoard director

Reported raises · per SEC filings

Form D private placements

$16.8M disclosed across 7 rounds · 2014–2019

▶$2MraisedAug 2019 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas DelaneyDirector
  • Bradley PaddockDirector
  • Brian JacksonExecutive Officer, Director
Offering amount
$10M
Amount sold
$2M
Placement agents
Commenda Securities LLC
First sale
Apr 2019
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedDec 2018 · 63 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian JacksonExecutive Officer, Director
  • Alex Powers, M.D.Director
  • Philip MessinaExecutive Officer, Director
  • Andrew RockExecutive Officer, Director
Offering amount
$6.8M
Amount sold
$5M
First sale
Sep 2018
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$100KraisedAug 2017 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • LAWRENCE G. SUCSYDirector
  • ANDY ROCKDirector
  • ALEXANDROS POWERSDirector
  • BRIAN J. JACKSONExecutive Officer, Director
  • PHILIP A. MESSINAExecutive Officer, Director
Offering amount
$4.5M
Amount sold
$100K
Minimum investment
$50K
Sales commissions
$6K
Placement agents
SF INVESTMENTS, INC.
First sale
Aug 2017
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$270KraisedMar 2016 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • BRIAN JACKSONExecutive Officer, Director
  • PHILIP MESSINAExecutive Officer, Director
  • LAWRENCE SUCSYDirector
Offering amount
$750K
Amount sold
$270K
First sale
Jan 2016
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.2MraisedOct 2015 · 38 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • LAWRENCE G. SUCSYDirector
  • PHILIP A. MESSINAExecutive Officer, Director
  • BRIAN JACKSONExecutive Officer, Director
Offering amount
$6.2M
Amount sold
$6.2M
Minimum investment
$50K
Sales commissions
$350K
Placement agents
SF INVESTMENTS, INC.
First sale
May 2015
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedMay 2015 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • BRIAN J. JACKSONExecutive Officer, Director
  • PHILLIP A. MESSINAExecutive Officer, Director
  • LAWRENCE SUCSYDirector
Offering amount
$5M
Amount sold
$2.1M
Minimum investment
$50K
Sales commissions
$350K
Placement agents
SF INVESTMENTS
First sale
May 2015
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedMar 2014 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • BRIAN J. JACKSONExecutive Officer, Director
  • Charles Timothy Floyd MDExecutive Officer
  • PHILLIP A. MESSINAExecutive Officer, Director
  • Dan FisherExecutive Officer
Offering amount
$3M
Amount sold
$1.1M
Minimum investment
$50K
Sales commissions
$75K
Finders' fees
$210K
Placement agents
SF Investments, Inc.
First sale
Feb 2014
Incorporated
Corporation, Minnesota, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as St Teresa Medical.

Frequently asked questions

What does St Teresa Medical do?
St Teresa Medical develops nanotechnology-based hemostatic and wound-healing solutions for surgical applications, derived from battlefield trauma treatment technology. The company targets the hemostatic and therapeutic markets with fibers designed to control bleeding and support wound healing during surgery.
How much funding has St Teresa Medical raised?
St Teresa Medical has disclosed $16.8M raised across 7 rounds.
Where is St Teresa Medical headquartered?
St Teresa Medical is headquartered in Woodbury, US.